Product How it works Pricing Blog FAQ About Contact
Boston Scientific

Boston Scientific (NYSE: BSX) net income

Boston Scientific reported a net profit of $2,892m for fiscal 2025, 56.7% more than in fiscal 2024 ($1,846m). Its net margin was 14.4%. Earnings per share were $1.96.

Net income, in millions of US dollars347.02016104.020171,67120184,7002019-82.020201,0412021698.020221,59220231,84620242,8922025

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$2,892m+56.7%14.4%$1.96
2024$1,846m+16.0%11.0%$1.26
2023$1,592m+128.1%11.2%$1.08
2022$698.0m−32.9%5.5%$0.45
2021$1,041m—8.8%$0.69
2020−$82.0m−101.7%−0.8%−$0.08
2019$4,700m+181.3%43.8%$3.38
2018$1,671m+1,506.7%17.0%$1.21
2017$104.0m−70.0%1.1%$0.08
2016$347.0m—4.1%$0.26

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the net income of Boston Scientific

How much did Boston Scientific earn in fiscal 2025?
Boston Scientific reported a net profit of $2,892m for fiscal 2025. In fiscal 2024 it reported a net profit of $1,846m.
What are the earnings per share of Boston Scientific?
They were $1.96 in fiscal 2025, compared with $1.26 in fiscal 2024.
What is the net margin of Boston Scientific?
In fiscal 2025 its net profit was 14.4% of its revenue.
What was the most profitable year for Boston Scientific?
Of its last 10 fiscal years, fiscal 2019, with $4,700m.
Where do the figures for Boston Scientific come from?
From the annual report (Form 10-K) that Boston Scientific files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Boston Scientific files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Boston Scientific: the Boston Scientific page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.